Parichart 2018
Parichart Naruphontjirakul, Ph.D.
Lecturer
Phone:
+66 (0)2-470-9366
Fax:
+66 (0)2-470-9391
Email:
This email address is being protected from spambots. You need JavaScript enabled to view it.
Research Interests:
  • Ceramic Biomaterials (Bioceramics)
  • Bioactive glasses
  • Polymeric biomaterials
  • Nanoparticles for drug delivery system
  • Bone regeneration

Education

  • 2018, Doctor of Philosophy in Biomaterials and Tissue engineering: Imperial College London, United Kingdom
  • 2011, Master of Science in Biological Engineering; King Mongkut’s University of Technology, Thonburi, Bangkok Thailand
  • 2006, Bachelor of Science in Biochemistry: Chulalongkorn University, Bangkok Thailand

Honors and Awards

  • Best Dissertation Award, The National Research Council of Thailand (NRCT) (2020)
  • The World Technology Universities Network (WTUN) 2019/2020 exchanges (2019)
  • Fourth World Technology University Congress (4th WTUC) (2019)
  • The Larry Hench Biomaterials Prize, Imperial College London, London UK (2019)
  • Royal Thai Government Scholarship (2014-2018)
  • Academic Excellence Scholarship, KMUTT (2009-2010)
  • Academic Merit Awards, Department of Biochemistry, Chulalongkorn University (2005-2006)
  • Toyota-Chulalongkorn Scholarship (2004-2006)
  • Academic Excellence Scholarship, Chulalongkorn University (2003-2006)

Publications

Journal Articles
  • Chen S., Greasley Sl., Ong ZY., Naruphontjirakul P., Page SJ., Hanna JV., Redpath AN., Rankin S., Ryan MP., Porter AE., Jones JR., 2020, “Biodegradable zinc-containing mesoporous silica nanoparticles for cancer therapy”, Materials Today Advances, Vol.6. 100066
  • Barrioni B., Naruphontjirakul P., Norris E., Li S., Jones J.and Pereira M.,2019, “Osteogenic potential of sol–gel bioactive glasses containing manganese”, Journal of Materials Science: Materials in Medicine, Vol. 30 No. 86, pp. 1-15
  • Naruphontjirakul P., and Viravaidya- Pasuwat, K., 2019, “Development of Anti-HER2 Targeted Doxorubicin-core Shell Chitosan Nanoparticles for the Treatment of Human Breast Cancer”, International Journal of Nanomedicine, Vol.14 pp. 4105-4121
  • Barrioni B., Naruphontjirakul P., Norris E., Li S., Hanna JV., Steven MM., Jones J. and Pereira M., 2019, “Effects of manganese incorporation on the morphology, structure and cytotoxicity of spherical bioactive glass nanoparticles”, Journal of Colloid and Interface Science, Vol. 547 pp. 382-392.
  • Naruphontjirakul P., Li S., Porter A. And Jones J., 2019, “Human mesenchymal stem cells (hMSCs) differentiate into an osteogenic lineage in presence of strontium containing bioactive glass nanoparticles”, Acta Biomaterialia, Vol. 90 pp.373-392.
  • Midha, S., Kumar, S., Sharma, A., Kaur, K., Shi, X., Naruphontjirakul, P., Jones, J. and Ghosh, S., 2018, “Silk fibroin-bioactive glass based advanced biomaterials: towards patient-specific bone grafts”, Biomedical Materials, Vol. 13, No. 5 (055012), pp. 1-19.
  • Naruphontjiracul, P., Porter, A.E. and Jones, J.R., 2018, “In vitro osteogenesis by intracellular uptake of strontium containing bioactive glass nanoparticles”, Acta Biomaterialia, Vol. 66, pp. 67-80, ISSN: 1742-7061.
  • Naruphontjirakul, P., Greasley, SL., Shu, C., Porter, AE. and Jones, JR., 2016, Monodispersed strontium containing bioactive glass nanoparticles and MC3T3-E1 cellular response”, Biomedical glasses, Vol. 2, pp. 2299-3932.
  • Naruphontjirakul P., Li S., Porter A., Jones J., Human mesenchymal stem cells (hMSCs) differentiate into an osteogenic lineage in presence of strontium containing bioactive glass nanoparticles. (in process)
  • Naruphontjirakul P., Chen S., Porter A., Jones J., Interaction of dense monodispersed strontium containing sol-gel derived bioactive glass nanoparticles with macrophages. (in process)
  • Barrioni B., Norris E., Li S., Naruphontjirakul P., Jones J., Pereira M., Evaluation of the osteogenic potential of bioactive glasses containing manganese obtained through from the sol-gel process. (in precess)
  • Naruphontjirakul, P., and Viravaidya-Pasuwat, K. 2011. Development of Doxorubicin – Core Shell O-succinyl Chitosan Graft Pluronic®127 Copolymer Nanoparticles to Treat Human Cancer. International Journal of Bioscience, Biochemistry and Bioinformatics Vol: 1, Page: 131 – 136.
Conference Proceedings
  • Barrioni B., Norris E., Li S., Naruphontjirakul P., Jones J., Pereira M., 2020, Sol-gel manganese-releasing bioactive glasses and their osteogenic potential, 11th World Biomaterials Congress WBC, Glasgow, Scotland
  • Naruphontjirakul P., 2019, "Cations doped nonporous silica nanoparticles," 12th Biomedical Engineering International Conference (BMEiCON), Ubon Ratchathani, Thailand, 2019, pp. 1-4, doi: 10.1109/BMEiCON47515.2019.8990288.
  • Barrioni B., Naruphontjirakul P., Norris E., Li S., Kelly N., Hanna JV., Steven MM., Jones J., Pereira M., 2019, “Spherical bioactive glass nanoparticles containing manganese for therapeutic delivery of ions”, XVIII Brazil MRS Meeting, Balneário Camboriú-SC, 22-26 September, 132
  • Naruphontjirakul, P., and Viravaidya-Pasuwat, K. Development of Doxorubicin-Core Shell Chitosan Nanoparticles to Treat Cancer. 2011 International Conference on Biomedical Engineering and Technology, IPCBEE vol.11 (2011) © (2011) IACSIT Press, Singapore.

 

Copyright© 2014 Biological Engineering, KMUTT All Rights Reserved